BOSTON (PRWEB) February 09, 2018
On Monday, Feb. 12, Greenberg Traurig, LLP’s Boston office will sponsor and host the Boston Healthcare Drinks’ event, featuring Dr. Preston Estep, Director of Gerontology and Director of Collections for the Personal Genome Project at Harvard University. Dr. Estep will share his insights on how genomics is changing human health and longevity.
Prior to Dr. Estep’s talk, Dr. Fang Xie and Wayne H. Elowe, leaders of the firm’s Biotechnology and Pharmaceutical Industry Group of the Global Life Sciences & Medical Technology Group, will discuss key IP and corporate issues that pharma and medical device companies should be aware of when doing business in China.
In 2016, Greenberg Traurig sponsored and hosted the launch of Healthcare Drinks’ Boston Chapter in the firm’s Boston office. Healthcare Drinks provides a platform for all sectors of management in the health care industry to meet, exchange ideas and socialize in a casual yet professional, educational and supportive atmosphere.
About Dr. Preston Estep
Dr. Estep performed his doctoral research at The Harvard Molecular Technology Group laboratory of genomics pioneer George Church. He is a Director of the Harvard Personal Genome Project. He is co-founder and Chief Scientific Officer of Veritas Genetics, a genetic testing company in the Boston area, which was recognized in 2016 and 2017 by MIT Technology Review as one of the world's 50 Smartest Companies.
Dr. Estep has co-founded and/or advised multiple startup companies and nonprofit organizations and is a frequent speaker to professional and public audiences. Dr. Estep is also Chairman and co-founder of the Mind First Foundation, which is dedicated to scientific research of the brain. He is the author of The Mindspan Diet, an examination of the longevity diets and genes throughout the world, which was published in 2016 by Ballantine Books/Random House.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing. As part of the group, the Biotechnology and Pharmaceutical Industry Group focuses on advising clients in the biotechnology and pharmaceutical sectors.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2017 Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.